Skip to main content
. 2004 May 19;2:1. doi: 10.1186/1478-4505-2-1

Table 1.

Program and Session Facilitators

Time Day 1 Day 2 Day 3 Day 4
9:00 – 10:30 Introduction and Course Overview
Dr Vasantha Muthuswamy – ICMR
Dr Peter A. Singer – University of Toronto
Dr Abdallah S. Daar – University of Toronto
Ethical guidelines for Medical Research in India
Dr N.K. Ganguly – ICMR
Intellectual Property Rights
Dr Malathi Lakshmikumaran – TERI
Opinion Leaders' Network
Dr Peter A. Singer
Dr Rakesh Dubey – Ocimum
Biosolutions
11:00–12:30 New Science 1 : Genomics
Dr S. S. Agarwal – ACTREC
DNA Vaccines – Relevance for India
Dr G. Padmanabhan – IISc
Business Models
Dr Chandu Nair – Scope Marketing & Knowledge
National Systems of Innovation
Dr Peter A. Singer
Public Health – Community Ownership
Dr Saraswathi Sankaran – DESH
2:00–3:30 New Science 2 : Stem Cells
Dr Dipika Mohanty – ICMR (Institute of Immunohaematology)
Indian Business Perspectives
Mr Khalil Ahmed – Shanta Biotech
Dr Krishna Ella – Bharath Biotech
Group Presentations
Biotechnology: From Benches to Bedside
Dr Rajesh Behl – Centre for Human Genetics
Group Presentations
4:00–5:30 Genomics and Global Health
Dr Abdallah S. Daar
Pharmaco-genomics
Dr C. M. Gupta – CDRI
Dr Vasantha Muthuswamy
Dr R. H. Jani – German Remedies
Legal Regulations of Genomics – Emerging Scenario
Dr Madhava Menon – WB National
University of Juridical Sciences
Summing up
Dr Sandhya Tewari – CII
Discussion & Closing – Dr Peter A. Singer